スペインで最高の神経内科医師 - トップ17名の医師

2,000人以上の患者が治療後に発作から解放されています。アントニオ・ルッシ教授はスペインで最高峰のてんかん専門医として認められています。

• 重症および希少てんかん症例に対する非外科的療法を専門とする
• 高度な脳波モニタリングを用いて薬物療法を個別化する
• テクノン病院のてんかんユニットを統括し、エピレプシー・ルッシ研究所を設立
• フォーブス誌「スペイン医師トップ100」に選出
• 国際患者向けの遠隔診療を提供する

50年の経験 最小侵襲脳神経外科の先駆者として、オリバー博士はCentro Médico Teknon脳腫瘍センターを率いています。

• 機能的脳神経外科財団の共同創設者
• 年間200件以上の高度脳・脊椎手術を執刀
• 欧州頭蓋底外科学会会長
• カロリンスカ研究所およびモントリオール神経学研究所にて研鑽
• 腫瘍の精密摘出を目的とした蛍光ガイド下手術を専門とする

Experience

• -Head of the Department of Functional Neurosurgery and Radiosurgery at Ruber International Hospital since 2005 .
• - Neurosurgeon in the Radiosurgery Department of Ruber International Hospital since 1993 .
• -Work experience at Puerta de Hierro Clinic, Madrid (1985–1989) .

Scientific and teaching activities

• -180 publications in national and international medical journals.
• 60 articles in leading international journals with high impact factor.
• - Participation in 230 scientific conferences as a speaker, including 100 invited presentations at international symposia.
• -Author : 3 published books and 22 chapters in scientific papers.
• - Honorary Professor of the Faculty of Medicine of the Autonomous University of Madrid .

Internships in international centers

• - La Timone Hospital, Marseille (France) – 2000, 2010, 2015.
• -Karolinska Hospital, Stockholm (Sweden) – 1993, 1996.
• - Birmingham Hospital, UK – 1987

Membership in scientific societies

• - Member of the International Society of Stereotactic Radiosurgery (ISRS) , is a member of the Executive Council and the Educational Committee .
• - Member of the Congress of Neurological Surgeons of the United States and the American Association of Neurological Surgeons .
• -Member of the Royal Academy of Medicine of Asturias, Spain .

Languages of practice

• -Spanish
• -English
• -French

Pathologies

-Benign brain tumors: meningiomas and neuromas:

-Cerebral vascular malformations:

-Obsessive-compulsive disorder treatment operations:

-Operations to combat nervous anorexia:

Publications

2023 | Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma in patients ≥ 65 years: a multi-institutional retrospective study Acta Neurochirurgica 165: 211–220,

2022 | Stereotactic radiosurgery for Kues grade IV vestibular schwannoma in young patients: a multi-institutional study Journal of Neuro-Oncology 160: 201–208.

2022 | Stereotactic radiosurgery versus active surveillance for asymptomatic, parafalcine, and parasagittal meningiomas: a matched cohort analysis from the IMPASSE Neurosurgery 90:750–757

2022| Active surveillance versus stereotactic radiosurgery for the treatment of patients with incident frontobasal meningioma - A subanalysis of the IMPASSE Cancers (Basel) trial. Mar 3;14(5):1300.

2022| Gamma Knife Outcomes and Recommendations and Complications: Patai fond Kuala Lumpur

2022| Radiosurgery for Mental Disorders LGKA Marsella

2022| The Role of SRS in Anorexia Nervosa ISRS Milan

2022| Expanding the indications for gamma knife radiosurgery Neuroonc and Rs Symp Malasia

2022 | Pituitary Adenoma: Conservative in Surgical Abortion Simp CUF Lisbo

Awards and certificates

2019|National Medical Prize XXI in the field of neurosurgery.

2018 | Editorial Board Member, American Journal of Psychiatry and Neurology

2015 | Factory Award torn away from the International Society of Stereotactic and Radiosurgery

2012 | Correspondent of the Real Medical Academy of Asturias.

Distinguished Doctor of Medicine and Surgery, University of Barcelona.

He is a specialist in neurology at the Hospital Clínic de Barcelona.

Dr. Pujol has teaching experience as Professor of Neurology at the Higher Institute of Psychological Studies (ISEP) and as Coordinator of the Neuropsychology Practicum at the University of the Balearic Islands (UIB).

Dr. Pujol's research interests are in the field of neurology: PhD thesis on neurological complications of liver transplantation; SNC manager at Parke Davis; Memory Research Unit coordinator at Sant Pau Hospital; researcher at the IUNICS group of the University of the Balearic Islands.

Dr. Pujol has publications in national and international journals and is a member of the neurology societies:

• American Academy of Neurology.
• Catalan Society of Neurology
• Catalan Academy of Medical Sciences

Specialist in Neurology
Head of the Advanced Neurosciences Unit – Quirónsalud

Professional Experience

Head of the Neurology Service
Hospital Universitario de Torrevieja (2018 – 2021)
Led a multidisciplinary neurology team with a focus on patient-centered care, especially for neurodegenerative disorders.

Head of Neurology Service
Hospital Clínica Benidorm (2017 – 2018)
Oversaw diagnostic and therapeutic services in general neurology, epilepsy, and movement disorders.

Consultant Neurologist
Hospital General Universitario de Alicante (2017 – 2018)
Specialized in inpatient and outpatient neurology services, actively participated in teaching and research.

Consultant Neurologist
Hospital de Manises, Valencia (2016 – 2017)
Focus on epilepsy and complex neurological diagnostics.

General Practitioner
Baghavatula Charitable Trust (BCT), Vishakapatnam, India (2012 – 2016)
Provided healthcare services in underserved rural communities, gaining valuable experience in global medicine.

Education & Training

Medical Degree
Universidad Autónoma de Madrid (UAM) (2005 – 2011)

Neurology Residency (MIR Program)
Hospital General Universitario de Alicante (2012 – 2016)

Postgraduate Studies

Postgraduate Specialization in Movement Disorders
Universidad Oberta de Catalunya (2019 – 2020)

Postgraduate Specialization in Clinical Research
Chair UAM-Abbvie (2020 – ongoing)

Master in Healthcare Management
UDIMA - Universidad a Distancia de Madrid (2020 – ongoing)

Master in Clinical Neurology
Universidad Francisco de Vitoria (2020 – ongoing)

Professional Societies

Member of the Valencian Society of Neurology (SVN)

Member of the Spanish Society of Neurology (SEN)

Scientific Contributions

Publications:

"Creutzfeldt-Jakob Disease – Heidenhain Variant" – Presented at the 66th Meeting of the Spanish Society of Neurology (2015)

"Sleepwalking or Epilepsy?" – Presented at the 39th Annual Meeting of the Spanish Society of Neuropediatrics (2016)

Conferences & Courses:

Epilepsy Hospital Stage Course – Hospital La Princesa, Madrid (2020)

Updates on Parkinson’s Disease and Movement Disorders – Movement Disorder Society, 2019

American Epilepsy Society Annual Meeting – Baltimore, USA (2019)

Since 1998 he has been Director of the Epilepsy Unit at the Ruber International Hospital in Madrid, a pioneering centre for the diagnosis, medical and surgical treatment of epilepsy in children and adults.

More than 150 neurologists and neurophysiologists from Spain and Latin America have been trained here, and several of its students have successfully opened epilepsy centres in other public and private hospitals, both in Spain and abroad.

The program he directs has become a pioneer in Spain in the field of genetic diagnosis of complex epilepsies and advanced treatments such as drug repositioning, interstitial laser treatment, deep electrodes and gamma radiosurgery, which are used in patients with refractory epilepsy.

Dr. Antonio Gil-Nagel is a professor at the IE University, is an Ad Honorem Professor at the Center for Biomedical Technology of the Polytechnic University of Madrid (CTB) and is Director of the Epilepsy Department at the Francisco Vitoria University of Madrid.

He was a founding member of the European Epilepsy Research Network and the European Association for Epilepsy Monitoring. He is also active in international research projects such as EpiCare and the European Epilepsy Brain Bank and has held relevant positions in international institutions such as the International Bureau for Epilepsy (IBE), the International League Against Epilepsy (ILAE), the European Federation of Neurological Societies (EFNS) and the World Federation of Neurology (WFN).

Dr. Gil-Nagel has directed numerous clinical trials and research studies in the field of epilepsy, especially in orphan epilepsies such as Dravet syndrome, Lennox-Gastaut syndrome and other epileptic and developmental encephalopathies. The Epilepsy Program he directs is an international benchmark in the development of pharmacological research. He has been the Principal Investigator of phase II and III clinical trials, including numerous clinical trials and non-pharmacological treatments (epilepsy surgery, electrical stimulation, ketogenic diet and gamma knife). His research is funded by European Union funds and the Public Innovation Agency of the Ministry of Science and Innovation of the Spanish Government. Their dedication to research and the development of new treatments allows them to accelerate the treatment of their patients with new treatments.

In addition to being a frequent speaker at national and international conferences, he has authored several books on epilepsy and electroencephalography and has numerous publications on epilepsy in journals such as Annals of Neurology, Brain, Epilepsy, European Journal of Neurology, Journal of Neurology, Nature Neurology, Neurology, and the New England Journal of Medicine, among others. He has authored 165 Scopus-indexed articles with 5,265 citations and an h-index of 35.

In 2021, his team received the Innovative Small and Medium Enterprise Award for the project on mesial temporal lobe epilepsy and encephalocele (Ministry of Science and Innovation, Spain), and in 2012, the Scientific Award from the Epilepsy Group of the Spanish Society of Neurology (SEN).

Education

• 1985 – Bachelor of Medicine and Surgery , Complutense University of Madrid.
• 1986-1989 – Specialization in Neurology , Hospital 12 de Octubre, Madrid.
• 1991–1993 – Epilepsy Specialist , Comprehensive Epilepsy Program, University of Minnesota, Minneapolis, USA.
• 1997 – Certification of the American Board of Clinical Neurophysiology .

Professional experience

• 1993–1995 – Associate Professor, Epilepsy Program, Department of Neurology, University of Minnesota, Minneapolis, USA.
• 1995–1998 – Associate Professor, Epilepsy Program, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, USA.
• Since 1998 – Director of the Epilepsy Program , Neurology Service, Ruber International Hospital, Madrid.
• 2014 – Defense of the dissertation on the topic: "Clinical and neurophysiological studies in the pre-surgical evaluation of epilepsy" , Complutense University of Madrid.
• 2022 – Deputy Head of the Neurology Service , Ruber Internacional International Hospital, Madrid.

Membership in professional societies

• Since 1991 – Member of the American Academy of Neurology (AAN).
• Since 1991 – Member of the American Epilepsy Society (AES).
• Since 1996 – Member of the American Society of Clinical Neurophysiology .
• Since 1988 – Member of the Spanish Society of Neurology .
• Since 2006 – Representative of Spain in the World Federation of Neurology (WFN).
• Since 2006 – Member of the editorial committee and the WFN web portal .
• Since 2008 – Director of the Epilepsy Group of the European Federation of Neurological Societies (EFNS).
• Since 2009 – Member of the EFNS Educational Courses Committee.
• 2007–2009 – Member of the EFNS Scientific Committee .
• 2007–2008 – Vice-President of the Scientific Committee of the 12th EFNS Congress , Madrid.
• 2004–2007 – Delegate of Spain to the EFNS .
• 2009 – Member of the Scientific Committee of the World Congress of Neurologists , Marrakech.

Outstanding Achievements

Dr. Hill-Nagel is a leading international figure in the field of epileptology, a recognized expert in the diagnosis and treatment of genetic epilepsy and the surgical approach to its correction. His distinguished professional career includes many years of experience in leading medical institutions in the United States and Europe, as well as active participation in international research and educational programs.

Dr. Hill-Nagel not only advances the science of neurology on a global level, but also successfully implements cutting-edge treatment methods, improving the lives of thousands of patients around the world.

Professional experience

Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.

Membership in scientific societies

National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)

President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).

Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).

Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).

Research and Teaching

Principal investigator of 100 national and international clinical trials.

7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).

10 projects from private foundations, received on a competitive basis (7 as principal investigator).

He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).

His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.

Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.

Education :

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Dr Romero Imbroda is an academic of the Royal Academy of Medicine of Eastern Andalusia and a Fellow of the European Board of Neurology, as well as a Member of the Board of Directors of the

Andalusian Society of Neurology. He combines his medical practice with his teaching role at the University of Granada, where he is a Lecturer and has been a Member of the Internal Residential Doctor Assessment Committee in Melilla until 2017.

He is the author of several national and international scientific publications. He has also participated in research projects associated with treatments for multiple sclerosis.

Professional Experience:

• 2020: President of the Andalusian Society of Neurology

• 2019: Head of the Units at the Quirónsalud Malaga and Marbella Hospitals

• 2017-2021: Neurologist at the Regional Malaga University Hospital.

• 2016-2017: Lecturer at the University of Granada.

• 2009-2017: Neurologist at the Imbrain Neuroscience Clinic. Melilla.

• 2009-2017: Neurologist at the Melilla Hospital.

• 2008-2009: Neurologist at the Virgen de las Nieves Hospital. Granada.

• 2004-2008: Neurologist at the Carlos Haya Hospital. Malaga.

Academic Training:

• 2017: Innovation and Leadership in Neurology. Business Institute. Madrid.

• 2014: Educational Commission for Foreign Medical Graduates. United States.

• 2011-2012: Management of Integrated Health Services. ESADE. Madrid.

• 2010: Neurologists for the Future. Spanish Neurology Society.

• 2010: Master in Tissue Engineering. University of Granada.

• 2010: Doctorate at the University of Granada. Summa Cum Laude. 2010.

• 2004-2008: Neurology specialist at the Carlos Haya Hospital. Malaga.

• 1997-2003: University Graduate in Medicine at the University of Granada.

The Neurology Unit of the Quirónsalud Marbella Hospital specialises in the study and treatment of conditions associated to the nervous system, the brain, the spinal cord, the peripheral nerves and the muscles. We have the most advanced technology that enables us to make accurate and personalised diagnoses and treatments in the study of patients with complex diagnoses and treatments (MRI, CT scan,electroencephalogram, transacranial doppler ultrasound, cerebral arteriogramand neuropschycological testing).

We offer our patients highly-specialised treatments for cerebrovascular and neuromuscular diseases, Parkinson's Disease, headaches and migraine, epilepsy, multiple sclerosis, peripheral neuropathies, infections of the nervous system, movement disorders, dementia and other cognitive conditions, paediatric neurology, sleep disorders, tumours and complications deriving from injuries to the spine and the head.

Dr. Oriol Franch is Head of Neurology at Hospital Ruber Internacional. He also leads the Neurology Service at Hospital La Luz (Madrid). He is a senior neurologist focused on complex diagnostic cases and second opinions. His specialties include neuro-ophthalmology, movement disorders (including Parkinson’s), neuromuscular diseases, and rare neurogenetic conditions.

He is a member of the Spanish Society of Neurology (SEN), the American Academy of Neurology (AAN), and the European Neurological Society (ENS). He has authored peer-reviewed articles on neuromuscular, neurodegenerative, genetic, toxic, and movement disorders. His work has been published in Acta Neuropathologica, Journal of Neurology, Journal of Neurology, Neurosurgery & Psychiatry, and Parkinsonism & Related Disorders.

Dr. Rodrigo Rocamora Zuniga is a neurologist who specializes in epilepsy. He leads the epilepsy department at HM Delfos Hospital in Spain. He is also a professor at UPF University. Dr. Rocamora earned his PhD from Bonn University in 2001. He completed his neurology training at Pontificia Universidad Católica de Chile and received his medical degree in Mendoza, Argentina.

Dr. Rocamora is accredited by the European Reference Network. He is an active member of SEN, CSUR, and EPI-Care. He has published over 100 scientific articles on drug-resistant epilepsy, epilepsy surgery, and cognitive impairment. His work has helped develop new protocols that have improved care for epilepsy patients.

Specialist in cell therapy

Dr. José Angel Obeso is a world renowned neurologist with over 40 years of experience and 30 years of research in movement disorders. He is the founder of the first specialized Movement Disorders Group of the Spanish Neurology Society and has developed Continuous Dopaminergic Stimulation for Parkinson's disease. He has authored over 350 research articles, and is a member of the American Neurological Association and the International Parkinson and Movement Disorder Society.